International Clinical Trial: Oral bioavailability study of proprietary extract of Fenugreek and Shatavari 300mg capsule under fasting condition

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117115) titled 'Oral bioavailability study of proprietary extract of Fenugreek and Shatavari 300mg capsule under fasting condition' on Sept. 7.

Study Type: BA/BE

Study Design: Randomized, Crossover Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Investigator Blinded

Primary Sponsor: OmniActive Health Technologies Ltd. India

Intervention: Intervention1: Product A contain proprietary extract of Fenugreek and Shatavari 300mg: 2 capsules each capsule containing 150 mg e...